March 29, 2022
A New York City investment firm asked a federal judge to let it intervene in a dispute over a $3.8 million international arbitration award against a biotechnology company that reneged on a financing deal, claiming its position as the company's only secured creditor could cost it millions in losses.
March 11, 2021
A New York-based trading firm has urged a federal judge to confirm a revised $3.6 million international arbitration award against a biotechnology company that reneged on a financing deal, arguing the arbitrator's third calculation is right on the money.
April 24, 2020
A New York federal judge on Friday granted a trading firm's request to set aside and remand, again, part of an award that had been left ambiguous by an arbitrator in a dispute over an alleged breach of a financing agreement with Generex Biotechnology Corp.
July 31, 2019
A biotechnology company will not have to pay a $3.6 million arbitration award to a trading firm over an alleged breach of a financing agreement just yet after a New York federal judge sent it back to the arbitrator for clarification on whether the amount was properly calculated.
February 19, 2019
A biotechnology company urged a New York federal court not to enforce an arbitration award issued to a trading firm over an alleged breach of a financing agreement, arguing that the $3.6 million award was improperly calculated based on the value of stock warrants that are actually worthless.
February 05, 2019
A New York-based trading firm has for a second time asked a federal court to enforce a more than $3.6 million international arbitration award against a biotechnology company, claiming it reneged on an exclusivity clause in an investor financing deal.
December 13, 2018
A trading firm asked a New York federal court on Tuesday to enforce a $3.6 million international arbitration judgment against a biotechnology company that reneged on a financial arrangement.